At the Ninth International Congress on Industrial Medicine Policard (1948) reported the production of granulomata in the lungs of rats and guinea-pigs by dusting with beryllium oxide. Details of the particle size of the dust were not given. Policard claimed that hyperplasia of the mesenchymatous cells of the lung after dusting with beryllium oxide resulted in three types of response (1) histiocytic pneumonia, (2) granulomatous nodules, mainly in guinea-pigs, and (3) Using the method we have previously described (Lloyd Davies and Harding, 1949) , we have introduced amorphous beryllium oxide into the lungs of 23 rats by the intratracheal injection of 50 mgm. beryllium oxide (75% of particles less than one micron in size) in 1 ml. of normal saline (pH of suspension 6 8) or of skimmed milk (pH of suspension 8 -0). The resultant histological changes are inconstant, but multiple small granulomata of foreign body type composed of small mononuclear cells (lymphocytes and histiocytes) with an occasional multinuclear cell and infiltration of the surrounding interstitial tissues by similar cells commonly result (Figs. 1, 2, and 3). The introduction by intratracheal injection of any dust, for example, zircon, manganese dioxide, silica, or graphite into the lung, if in sufficient quantity and of the right particle size, may lead to foreign body granulomata as a normal or physiological reaction (Fig. 6 ). Occasionally, larger and different granulomata appear after the intratracheal injection of beryllium oxide, especially when some further stimulus to histiocytic proliferation is present. Eleven additional rats were injected with a mixture of 50 mg. each of beryllium oxide and manganese dioxide in sterile suspension (pH 6 5). A granuloma resulting from such an injection is illustrated in Figs. 4 Policard has not made further reports of his shown that it evoked a response that was characteristically observations; his microhistological slides were histiocytic, and partly because fluorescent powders used unsatisfactory since the magnification was so great that the lung field surrounding the single granuloma was not visible. At first we interpreted our results as foreign body granulomata, but we now believe that at least some of the granulomata we produced are related specifically to beryllium oxide. A granuloma of the type illustrated in Fig. 5 has a highly cellular character, and when associated with infiltration of the interstitial tissues represents the reaction of the lung to chronic irritation. To this extent the reaction we produced may be a similar, although limited, type of reaction to that in chronic (beryllium) granulomatosis in the human subject. We emphasize that the technique we have adopted is very artificial; a single large dose of dust is far from comparable with repeated inhalations of small quantities such as occur in the human subject.
The occurrence of granulomata in the lungs of rats is, in our opinion, associated with the rate of solution of the particles, which is determined by the size of the particle and the solubility of beryllium. Reactions such as granulomata, which are of a chronic nature, occur when particulate dust persists in aggregations to form a continuing irritant focus. Beryllium oxide is relatively insoluble and disappears slowly from the lung. In the case of manganese its greater solubility does not allow of the formation of large granulomata, although small multiple granulomatous follicles are not infrequent (Lloyd Davies and Harding, 1949) . All work on beryllium granulomatosis and other dust diseases must include consideration of the particle size and solubility. Possibly large, well-formed granulomata result only when the action of beryllium is reinforced by that of some other agent or agents provoking a proliferation of histiocytes. Our best examples were seen when manganese dioxide was injected with the beryllium oxide. Most, and possibly all, of the dusts that have produced chronic granulomatosis in man are mixtures containing such substances as manganese, silica and zinc. 
